CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Care Rx Corporate Office

Care Rx Corporate Office is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthAmerica Pennsylvania

HealthAmerica Pennsylvania, Inc. is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carolinas Hospital System

Carolinas Hospital System is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Florence, SC. To find more information about Carolinas Hospital System, please visit www.carolinashospital.com

Nexeon MedSystems

Nexeon MedSystems is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Partners Technology Inc

Health Partners Technology Inc is a Stoneham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.